Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
09/2001
09/13/2001WO2001066099A2 Use of quinazoline derivatives as angiogenesis inhibitors
09/13/2001WO2001012615A3 Fungicidal heteroaryl hepta-2,6-dienoic acid derivatives
09/13/2001WO2000032573A8 A meta-nitro phenol derivative and a process for producing it
09/13/2001US20010021388 Cyclization of a triether with a diamine compound
09/13/2001DE10028687A1 New benzoyl substituted thio-cyclohexenone derivatives useful as herbicides, especially for weed control in crops
09/13/2001CA2401903A1 Substituted benzoylcyclohexenones
09/12/2001EP1132433A2 Water-soluble fibre-reactive dyestuffs, process for their preparation and their use
09/12/2001EP1132387A1 Pyrimidinylbenzimidazole and triazinylbenzimidazole derivatives and agricultura/horticultural bactericides
09/12/2001EP1132382A1 3-Oxy-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadazine-1,1-dioxide derivatives having diuretic and/or natriuretic activity
09/12/2001EP1132377A1 Propiolonitrile derivatives and liquid crystal compositions comprising the same
09/12/2001EP1131319A2 3- benz(ox/thi)azol-7-yl -1h-pyrimidine-2,4-diones
09/12/2001EP1131318A1 Process for making 5-substituted pyrazoles using dithietanes
09/12/2001EP1131312A1 Novel pyrimidine derivatives and processes for the preparation thereof
09/12/2001EP1131304A1 N- 4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, an irreversible inhibitor of tyrosine kinases
09/12/2001EP1131303A1 Crystalline (-)-6- chloro-4- cyclopropylethynyl- 4-trifluoromethyl- 3,4-dihydro- 2(1h)-quinazolinone
09/12/2001EP1131302A1 Substituted 4-amino-2-aryl-cyclopenta d]pyrimidines, their production and use and pharmaceuticalreparations containing same
09/12/2001EP1131270A1 Process for converting an alcohol to the corresponding fluoride
09/12/2001EP0817775B1 Quinazoline derivatives
09/12/2001EP0794945B1 Iminooxybenzylcrotonic acid esters, process for their preparation and use thereof
09/12/2001EP0790987B1 Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
09/12/2001CN1312807A Inhibitors of glycogen synthase kinase 3
09/12/2001CN1312729A Dry powder dispersing apparatus and method therefor
09/12/2001CN1070841C Carboxylic acid derivatives, their preparation and their use
09/12/2001CN1070702C Use of 2,4-diamino pyrimidine 3-oxide or its salt thereof for treating collegen maturation and structuring disorders
09/12/2001CN1070701C Pyrimidine ortriazine carboxylic acid derivatives to be used as medicaments
09/11/2001US6288267 Thioamide derivatives
09/11/2001US6288231 Peptide-containing α-ketoamide cysteine and serine protease inhibitors
09/11/2001US6288151 Alkylated aminoalkyl cyclic urea surfactants
09/11/2001US6288120 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
09/11/2001US6288086 N-hydroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
09/11/2001US6288068 Administering 1,4-disubstited piperidine derivative; alzheimer*s disease, cognition activators; anticholinergic agents
09/11/2001US6288060 Corticotropin releasing factor antagonists; anxiolytic, antidepressant, antiinflammatory agents; eating disorders
09/11/2001US6288055 Analgesic agents
09/07/2001WO2001064814A1 Supertwisted nematic liquid crystal displays, liquid crystal compositions and compounds
09/07/2001WO2001064656A1 2,4,di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
09/07/2001WO2001064655A1 2, 4-di(hetero-)arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents
09/07/2001WO2001064654A1 Pyrimidine compounds
09/07/2001WO2001064653A1 Pyrimidine compounds
09/07/2001WO2001055111A8 Biaryl compounds, their preparation and their use in therapy
09/07/2001WO2001019780A3 Novel derivatives of dicarboxylic acid having pharmaceutical properties
09/07/2001CA2399704A1 Pyrimidine compounds
09/07/2001CA2398685A1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
09/06/2001US20010020092 Nitro-sulfobenzamides
09/06/2001US20010020022 2{3-[4-(2-t-butyl-6-trifluoromethylpyridin-4-yl) piperazin-1-yl] propylmercapto} pyrimidin-4-ol-fumarate
09/06/2001US20010020021 Metalloprotease inhibitor
09/06/2001US20010020013 Polymerase inhibitors
09/06/2001DE10010726A1 Twisted and supertwisted liquid crystal display, e.g. matrix display, has liquid crystal mixture containing fluoro-cyanopyrimidinyl-benzene and phenyl-cyclohexyl-cyclohexane compounds
09/05/2001EP0832061B1 Benzamide derivatives and their use as vasopressin antagonists
09/05/2001EP0801527A4 Pharmaceutical compositions for prevention and treatment of central nervous system disorders
09/05/2001EP0768998B1 Liquid crystal compounds, mixtures and devices
09/05/2001EP0699185B1 GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS
09/05/2001EP0637300B1 Antiproliferative quinazolines
09/05/2001CN1311782A Method for producing 4,6-disubstituted 2-isocyanatopyrimidines and to their use as intermediate products for active ingredient syntheses
09/05/2001CN1311768A Crosslinkable liquid crystalline compound
09/04/2001US6284796 Naphthamidine compounds
09/04/2001US6284767 Retroviral protease inhibiting compounds
09/04/2001US6284764 Antiproliferative agent
08/2001
08/30/2001WO2001062743A2 Method for the simplified production of (3-chloro-4-fluoro-phenyl)-[7-(3-morpholino-4-yl-propoxy)-6-nitro-quinazoline-4-yl]-amine or (3-chloro-4-fluoro-phenyl)-[7-(3-morpholino-4-yl-propoxy)-6-amino-quinazoline-4-yl]-amine
08/30/2001WO2001062742A1 Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
08/30/2001WO2001062731A1 Pyridine-amidines as modulators of p38 map kinase
08/30/2001WO2001062704A1 Novel use of phenylheteroalkylamine derivatives
08/30/2001WO2001062294A1 Preventive or therapeutic drugs for dermatitises containing chymase inhibitors as the active ingredient
08/30/2001WO2001062293A1 Preventive or therapeutic drugs for various eosinophilia-related diseases containing chymase inhibitors as the active ingredient
08/30/2001WO2001062292A1 Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as the active ingredient
08/30/2001WO2001062233A2 Adenosine receptor modulators
08/30/2001WO2001016131A3 Five membered-ring compounds and utilization thereof in liquid crystal mixtures
08/30/2001US20010018518 Chemical intermediate for hypotensive agents, bactericides, fungicides, antipyretics and antidepressants
08/30/2001US20010018443 Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds
08/30/2001US20010018442 Fungicides
08/30/2001US20010018436 Pyrimidine derivatives
08/30/2001US20010018405 For use as plant protecting fungicides, by reacting an orthocarbonate with a compound such as a 2-(1,1-dipropoxymethyleneamino)thiophene-3-carboxylic acid propyl amide and cyclizing the resulting intermediate
08/30/2001DE10102631A1 Thiophencarbonsäureester und flüssigkristallines Medium Thiophencarbonsäureester and liquid crystalline medium
08/30/2001DE10009267A1 Verfahren zur einfachen Herstellung von (3-Chlor-4-fluor-phenyl)-[7-(3-morpholin-4-yl-propoxy)-6-nitro-quinazolin-4-yl]-amin bzw. (3-Chlor-4-fluor-phenyl)-[7-(3-morpholin-4-yl-propoxy)-6-amino-quinazolin-4-yl]-amin A process for the simple production of (3-chloro-4-fluoro-phenyl) - [7- (3-morpholin-4-yl-propoxy) -6-nitro-quinazolin-4-yl] -amine or (3-chloro -4-fluoro-phenyl) - [7- (3-morpholin-4-yl-propoxy) -6-amino-quinazolin-4-yl] -amine
08/30/2001CA2401190A1 Pyridine-amidines as modulators of p38 map kinase
08/30/2001CA2401171A1 Process for the simple preparation of(3-chloro-4-fluorophenyl)-[7-(3-morpholin-4-yl-propoxy)-6-nitroquinazolin-4-yl]-amine or (3-chloro-4-fluorophenyl)-[7-(3-morpholin-4-yl-propoxy)-6-aminoquinazoline-4-yl]-amine
08/30/2001CA2397234A1 Novel use of phenylheteroalkylamine derivatives
08/30/2001CA2368382A1 Medicament for prevention and treatment of dermatitis having chymase inhibitor as effective ingredient
08/30/2001CA2368366A1 Medicament for prevention or treatment of fibrosis having chymase inhibitor as effective ingredient
08/30/2001CA2365606A1 Medicament for prevention or treatment of various diseases involving an increase in eosinophils chymase inhibitor as effective ingredient
08/29/2001EP1127923A2 Water-soluble fibre-reactive dyestuffs, process for their preparation and their use
08/29/2001EP1127573A1 Compostitions and methods for treating osteoporosis
08/29/2001EP1127053A1 Novel 1-aryl-4-thiouracils
08/29/2001EP1126838A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
08/29/2001EP0889877B1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS
08/29/2001EP0772652B1 Reactive monoazo dyestuffs
08/29/2001CN1310714A Substituted benzoylcyclohexandiones
08/29/2001CN1310713A Substituted quinazoline derivatives
08/29/2001CN1310709A N.N-substituted cyclic amine derivatives
08/29/2001CN1310629A Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions
08/29/2001CN1309970A Application of uridine phosphorylase inhibitor and composition containing the same
08/29/2001CN1309898A Pesticide containing 0-benzyl oximeether derivative and its use
08/28/2001US6281363 Antiinflammatory agents; antiarthritic agents; autoimmune disorders
08/28/2001US6281359 Psychological disorders
08/28/2001US6281358 Process for the preparation of substituted pyrimidines
08/28/2001US6281338 Mono- and dipotassium salts of azo compounds
08/28/2001US6281219 Acaricidal and insecticidal substituted pyrimidines and a process for the preparation thereof
08/28/2001CA2017252C Retroviral protease inhibiting compounds
08/23/2001WO2001060825A1 Pyrrolopyrimidinone derivatives, process of preparation and use
08/23/2001WO2001060816A1 Kinase inhibitors
08/23/2001WO2001060805A1 Pyrimidine-4-one derivatives as ldl-pla2 inhibitors